Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer

Figure 1

CD44 immunostaining in TNBC. (a) Low membrane and cytoplasmic expression (40x). (b) High membrane and cytoplasmic expression (40x). (c) High membrane expression (40x).

(a)

(b)

(c)